Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.05M | -2.83M | -24.66M | -25.43M | -11.77M |
| Total Depreciation and Amortization | 452.80K | 419.90K | 444.00K | 457.90K | 423.00K |
| Total Amortization of Deferred Charges | 1.10K | 1.10K | 1.10K | 1.10K | -- |
| Total Other Non-Cash Items | -8.22M | -7.63M | 15.82M | 16.31M | 1.62M |
| Change in Net Operating Assets | 944.80K | 876.10K | 1.08M | 1.12M | 6.59M |
| Cash from Operations | -9.88M | -9.16M | -7.31M | -7.54M | -3.14M |
| Capital Expenditure | -85.10K | -78.90K | -190.30K | -196.20K | -263.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.80K | -6.30K | -52.20K | -53.90K | -5.90K |
| Cash from Investing | -91.90K | -85.20K | -242.50K | -250.10K | -269.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.25M | -1.25M | -1.05M | -1.05M | -1.02M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -168.00K | -168.00K | -185.50K | -185.50K | -304.50K |
| Cash from Financing | -1.61M | -1.49M | -1.32M | -1.36M | -1.43M |
| Foreign Exchange rate Adjustments | -292.20K | -271.00K | 27.20K | 28.00K | 23.10K |
| Miscellaneous Cash Flow Adjustments | -600.00 | -500.00 | 500.00 | 600.00 | -- |
| Net Change in Cash | -11.87M | -11.01M | -8.85M | -9.12M | -4.82M |